Literature DB >> 26341496

Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer.

Jing Li1, Siqin Yang2, Ning Su3, Yuan Wang4, Jinjin Yu4, Haifeng Qiu5, Xiaoying He6.   

Abstract

Overexpression of HOTAIR (HOX antisense intergenic RNA) is significantly correlated with tumor progression and poor prognosis in human ovarian cancer. However, the underlying mechanisms are largely unknown. In the present study, we investigated the roles of HOTAIR in the initiation and chemoresistance of ovarian cancer. As our data show, HOTAIR overexpression promoted cell cycle progression (and thus cell proliferation) by activating the wnt/β-catenin signaling pathway. Likewise, knockdown of HOTAIR suppressed cell proliferation and arrested cell cycle at G1 phase via inhibition of wnt/β-catenin signaling. Moreover, the results of primary culture demonstrated that elevated HOTAIR expression correlated positively with chemoresistance in ovarian cancer. In vitro and in vivo, HOTAIR induced cellular resistance to cisplatin by activating the wnt/β-catenin pathway, which could be reversed by pre-treatment with the wnt/β-catenin inhibitor, XAV939. In conclusion, HOTAIR promotes the initiation and chemoresistance of ovarian cancer by activating wnt/β-catenin signaling, suggesting that HOTAIR might be a potent therapeutic target for ovarian cancer treatment.

Entities:  

Keywords:  Cell cycle; Chemoresistance; HOTAIR; Long non-coding RNA; Ovarian cancer; Proliferation

Mesh:

Substances:

Year:  2015        PMID: 26341496     DOI: 10.1007/s13277-015-3998-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  24 in total

Review 1.  LncRNA: a link between RNA and cancer.

Authors:  Guodong Yang; Xiaozhao Lu; Lijun Yuan
Journal:  Biochim Biophys Acta       Date:  2014-08-23

Review 2.  Long non-coding RNAs: insights into functions.

Authors:  Tim R Mercer; Marcel E Dinger; John S Mattick
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

3.  HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway.

Authors:  Xiao-Song Ge; Hua-Juan Ma; Xiao-Hui Zheng; Hong-Lian Ruan; Xiao-Yu Liao; Wen-Qiong Xue; Yuan-Bin Chen; Ying Zhang; Wei-Hua Jia
Journal:  Cancer Sci       Date:  2013-10-30       Impact factor: 6.716

Review 4.  Ovarian cancer.

Authors:  Gordon C Jayson; Elise C Kohn; Henry C Kitchener; Jonathan A Ledermann
Journal:  Lancet       Date:  2014-04-21       Impact factor: 79.321

Review 5.  Overcoming platinum resistance in ovarian carcinoma.

Authors:  Koji Matsuo; Yvonne G Lin; Lynda D Roman; Anil K Sood
Journal:  Expert Opin Investig Drugs       Date:  2010-09-06       Impact factor: 6.206

6.  Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma.

Authors:  Dandan Li; Jiapeng Feng; Tianyi Wu; Yandong Wang; Yanan Sun; Jingyuan Ren; Ming Liu
Journal:  Am J Pathol       Date:  2012-11-07       Impact factor: 4.307

7.  Long noncoding RNA as modular scaffold of histone modification complexes.

Authors:  Miao-Chih Tsai; Ohad Manor; Yue Wan; Nima Mosammaparast; Jordon K Wang; Fei Lan; Yang Shi; Eran Segal; Howard Y Chang
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

8.  Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.

Authors:  Jun-jun Qiu; Ying-ying Lin; Le-chi Ye; Jing-xin Ding; Wei-wei Feng; Hong-yan Jin; Ying Zhang; Qing Li; Ke-qin Hua
Journal:  Gynecol Oncol       Date:  2014-03-22       Impact factor: 5.482

Review 9.  Long noncoding RNAs and the genetics of cancer.

Authors:  S W Cheetham; F Gruhl; J S Mattick; M E Dinger
Journal:  Br J Cancer       Date:  2013-05-09       Impact factor: 7.640

10.  Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer.

Authors:  Xiang-Hua Liu; Ming Sun; Feng-Qi Nie; Ying-Bin Ge; Er-Bao Zhang; Dan-Dan Yin; Rong Kong; Rui Xia; Kai-Hua Lu; Jin-Hai Li; Wei De; Ke-Ming Wang; Zhao-Xia Wang
Journal:  Mol Cancer       Date:  2014-04-28       Impact factor: 27.401

View more
  55 in total

1.  High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both In Vivo and In Vitro.

Authors:  Fan Wang; Jeremy T-H Chang; Chester Jingshiu Kao; R Stephanie Huang
Journal:  Mol Cancer Ther       Date:  2016-02-12       Impact factor: 6.261

2.  The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo.

Authors:  Pengcheng Li; Xun Zheng; Kangquan Shou; Yahui Niu; Chao Jian; Yong Zhao; Wanrong Yi; Xiang Hu; Aixi Yu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 3.  Regulatory role of long non-coding RNAs during reproductive disease.

Authors:  Kangsheng Liu; Xiaodong Mao; Yajun Chen; Taiping Li; Hua Ton
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

4.  Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.

Authors:  Selin Oncul; Paola Amero; Cristian Rodriguez-Aguayo; George A Calin; Anil K Sood; Gabriel Lopez-Berestein
Journal:  RNA Biol       Date:  2019-12-17       Impact factor: 4.652

5.  Comprehensive analysis of long noncoding RNA (lncRNA)-chromatin interactions reveals lncRNA functions dependent on binding diverse regulatory elements.

Authors:  Guanxiong Zhang; Yujia Lan; Aimin Xie; Jian Shi; Hongying Zhao; Liwen Xu; Shiwei Zhu; Tao Luo; Tingting Zhao; Yun Xiao; Xia Li
Journal:  J Biol Chem       Date:  2019-09-04       Impact factor: 5.157

6.  Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer.

Authors:  Stephen Shang; Jiekun Yang; Amir A Jazaeri; Alexander James Duval; Turan Tufan; Natasha Lopes Fischer; Mouadh Benamar; Fadila Guessous; Inyoung Lee; Robert M Campbell; Philip J Ebert; Tarek Abbas; Charles N Landen; Analisa Difeo; Peter C Scacheri; Mazhar Adli
Journal:  Cancer Res       Date:  2019-07-29       Impact factor: 12.701

7.  53BP1 inhibits the migration and regulates the chemotherapy resistance of ovarian cancer cells.

Authors:  Shuhui Hong; Xiaoyan Li; Ying Zhao; Qifeng Yang; Beihua Kong
Journal:  Oncol Lett       Date:  2018-04-27       Impact factor: 2.967

8.  LncRNA HOTAIR promotes cisplatin resistance in gastric cancer by targeting miR-126 to activate the PI3K/AKT/MRP1 genes.

Authors:  Jin Yan; Yini Dang; Shiyu Liu; Yifeng Zhang; Guoxin Zhang
Journal:  Tumour Biol       Date:  2016-11-30

9.  Emerging role of lncRNA in cancer: a potential avenue in molecular medicine.

Authors:  Nidhi Jariwala; Devanand Sarkar
Journal:  Ann Transl Med       Date:  2016-08

10.  Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells.

Authors:  Chencheng Dai; Pengfei Xu; Siyu Liu; Sujuan Xu; Juan Xu; Ziyi Fu; Jian Cao; Mingming Lv; Juan Zhou; Guangquan Liu; Huilin Zhang; Xuemei Jia
Journal:  Arch Gynecol Obstet       Date:  2020-11-05       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.